Previous Close | 79.43 |
Open | 79.54 |
Bid | 79.85 x 900 |
Ask | 79.82 x 800 |
Day's Range | 79.32 - 80.75 |
52 Week Range | 64.41 - 83.25 |
Volume | |
Avg. Volume | 11,295,378 |
Market Cap | 100.374B |
Beta (5Y Monthly) | 0.50 |
PE Ratio (TTM) | 12.33 |
EPS (TTM) | 6.47 |
Earnings Date | May 01, 2024 - May 06, 2024 |
Forward Dividend & Yield | 2.66 (3.34%) |
Ex-Dividend Date | Apr 19, 2024 |
1y Target Est | 87.85 |
Subscribe to Yahoo Finance Plus to view Fair Value for CVS
The first major U.S. health insurers have agreed to start paying for the popular anti-obesity drug Wegovy for certain people on Medicare with heart-related conditions.
CVS Health (CVS) concluded the recent trading session at $79.43, signifying a +0.14% move from its prior day's close.
CVS Health® (NYSE: CVS) today announced more than $3 million in new grants to support organizations in Phoenix working to increase equitable access to health care, address social determinants of health and educate the community on the effects of air pollution. This announcement was made during a Project Health event in Phoenix and included CVS Health leaders, community organizations and local officials.